SLNCF — Silence Therapeutics Share News
0.000.00%
- $902.88m
- $830.82m
- $0.56m
Silence Therapeutics - Holding(s) in Company
Silence Therapeutics - Total Voting Rights
Silence Therapeutics - Notice of half year results
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 02:59 PM
Silence Therapeutics - Results of Annual General Meeting
Silence Therapeutics - Silence to present SL124 data at EHA
NASDAQ RESUMED AT 01:15 PM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 01:10 PM
NASDAQ RESUMED AT 01:06 PM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 12:56 PM
NASDAQ RESUMED AT 12:52 PM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 12:47 PM
Brief: Silence Therapeutics Gets $40 Mln Payment From AstraZeneca For Collaboration
Silence Therapeutics - $40m Payment from AstraZeneca for Collaboration
Brief: Silence Therapeutics Announces Positive Data From Gemini Phase 1 Study Of SLN124 In Healthy Volunteers
Silence Therapeutics - Phase 1 Study in Healthy Volunteers Positive Data
Silence Therapeutics - Silence attends RBC Global Healthcare Conference
Silence Therapeutics - Notice of AGM
RCS - Silence Therapeutics - Silence Support International Thalassemia Day